Target intelligence / Profile preview

Exposed primary amine groups on self-proteins

Molecular classification
Other
01

Overview

Exposed primary amine groups on self-proteins, primarily the ε-amino groups of lysine residues and the α-amino groups at the N-termini, are critical chemical sites for both physiological processes and pathological modifications (PubMed, PMID: 25611107). Biologically, these amines are involved in essential post-translational modifications, such as the formation of desmosine cross-links in elastin and collagen catalyzed by lysyl oxidase, which provide structural integrity to tissues (UniProt, P06737). In the context of disease, these groups are the primary targets for non-enzymatic glycation by reducing sugars, leading to the accumulation of advanced glycation end-products (AGEs) associated with diabetic complications and aging (NIH, StatPearls). Furthermore, these amines serve as the reactive sites for "haptens"—small molecules like penicillin or reactive drug metabolites—that covalently bind to self-proteins to form immunogenic complexes, potentially triggering severe hypersensitivity reactions or drug-induced autoimmunity (PubMed, PMID: 11526240). In biotechnology and medicine, these groups are intentionally targeted for the chemical fixation of bioprosthetic tissues using glutaraldehyde or for the site-specific conjugation of polymers and drugs to therapeutic proteins (PubMed, PMID: 10658700).

Other names
Protein lysine residuesProtein N-terminal aminesEpsilon-amino groups of lysineProtein primary aminesHapten binding sitesGlycation sites
02

Mechanism of action

Covalent modification including acylation, alkylation, glycation, or cross-linking of primary amine groups (lysine side chains or N-termini) on endogenous proteins.

03

Biological functions

Other
04

Disease associations

InflammationDiabetesNeurodegenerative diseaseCardiovascular disease
05

Safety considerations

Drug-induced hypersensitivityAutoimmunityLoss of protein functionTissue calcification
06

Interacting drugs

Penicillin

6 more in the full profile.

07

Biomarkers

HbA1cAdvanced Glycation End-products (AGEs)Drug-protein adductsAnti-drug antibodies

Beyond the preview

Go deeper on Exposed primary amine groups on self-proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Exposed primary amine groups on self-proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call